Citation Impact
Citing Papers
Fusobacterium nucleatumin Periodontal Health and Disease
2011
Myofibroblasts and mechano-regulation of connective tissue remodelling
2002 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Microbial etiological agents of destructive periodontal diseases
1994 Standout
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Photodynamic Therapy
1998 Standout
Connective tissue growth factor: a mediator of TGF-β action on fibroblasts
1997 Standout
Abdominal aortic aneurysm
2005 Standout
Cystatin C deficiency in human atherosclerosis and aortic aneurysms
1999
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis
2000
Development of a Classification System for Periodontal Diseases and Conditions
1999 Standout
Lysosomes as photochemical targets
1994
Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes
2003
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Matrix Metalloproteinases and Other Matrix Proteinases in Relation to Cariology: The Era of ‘Dentin Degradomics'
2015 Standout
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms
2002 Standout
Case Definitions for Use in Population‐Based Surveillance of Periodontitis
2007 Standout
Lysosomes and Microtubules as Targets for Photochemotherapy of Cancer
1997
The phospholipase A2 superfamily and its group numbering system
2006 Standout
Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer
2010
Periodontal Diseases: Diagnosis
1996
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
2011 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Photodynamic therapy of cancer: An update
2011 Standout
The interleukin‐1 genotype as a severity factor in adult periodontal disease
1997 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Function of Peritoneal Exudate Cells after Abdominal Surgery
1993
Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization
2004 Standout
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases
1993
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
The effect of treatment on IgG, IgA, IgM and α-2-macroglobulin in gingival crevicular fluid from patients with chronic adult periodontitis
1988
Mechanistic features associated with induction of metalloproteinases in human gingival fibroblasts by interleukin-1
1994
Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
1992 Standout
Periodontal bone level and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis
1991
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Cysteine Proteinases and Their Inhibitors in Extracellular Fluids: Markers for Diagnosis and Prognosis in Cancer
2000
Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencing
1986
Gamma‐interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages
1995
Production of large amounts of hydrogen peroxide by human tumor cells.
1991 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases
1986
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
1995 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Cystatins — Inhibitors of Cysteine Proteinases
1992
von Hippel-Lindau Disease
2006 StandoutNobel
Cysteine Peptidases of Mammals: Their Biological Roles and Potential Effects in the Oral Cavity and Other Tissues in Health and Disease
2002
Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolytic system
1987
Peritoneal Adhesions: Etiology, Pathophysiology, and Clinical Significance
2001 Standout
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator
1990 StandoutNobel
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
2006 Standout
Acidic pH enhances the invasive behavior of human melanoma cells
1996
Basic principles of photodynamic therapy
2001 Standout
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
2002 StandoutNobel
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
CELLULAR RESPONSES TO INTERFERON-γ
1997 Standout
Assembly of the 26 S complex that degrades proteins ligated to ubiquitin is accompanied by the formation of ATPase activity.
1990 StandoutNobel
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
1987
The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1
1998 Standout
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
1988 Standout
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
2000 StandoutNobel
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Matrix Metalloproteinases: A Review
1993 Standout
Abdominal Aortic Aneurysm
2006 Standout
Tumors: Wounds That Do Not Heal
1986 Standout
The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.
1988 StandoutNobel
Regulation of endothelial cell coagulant properties
1989
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
1987
The cellular and molecular biology of plasminogen activator inhibitor type-2
1995
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids
2003 Standout
Works of J. Babnik being referenced
Cystatins and stefins in ascites fluid from ovarian carcinoma
1992
Stefins and lysosomal cathepsins B, L and D in human breast carcinoma
1992
Immunochemical quantitation of cysteine proteinase inhibitor cystatin C in inflamed human gingiva
1989
Immunological studies of the toxic site in ammodytoxin A
1991
Cathepsin D, L and B in inflamed human gingiva
1985
Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators
1985
Alpha 2‐macroglobulin in gingival fluid: correlation with alveolar bone loss in periodontal disease
1986
Detection of cathepsin L‐like proteinase and cathepsin D in gingival fluid
1986
Immunochemistry of leucocyte intracellular proteinase inhibitors
1983
Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease.
1993
Structure and function of lysosomal cysteine proteinases and their protein inhibitors.
1985
Cysteine proteinase inhibitors in inflamed human gingiva.
1988